Elizabeth A Brem (Elizabeth Brem)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Chronic Lymphocytic Leukemia

Atomic Force Microscopy

Top Venues

JCO oncology practice

Clinical case reports

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Bradley M Haverkos, Onder Alpdogan, Robert A Baiocchi, Jonathan E Brammer, Tatyana Feldman, Marcelo Capra, Elizabeth A Brem, Santosh Nair, Phillip Scheinberg, Juliana Pereira, Leyla Shune, Erel Joffe, Patricia Young, Susan E Spruill, Afton Katkov, Robert McRae, Ivor Royston, Douglas V Faller, Lisa Rojkjaer, Pierluigi Porcu
Targeted therapy with nanatinostat and valganciclovir in recurrent Epstein-Barr virus-positive lymphoid malignancies: a Phase 1b/2 study. Blood advances (2023)
Benjamin J Lee, Yen Cao, Pongthep Vittayawacharin, Ghaydá É'Leima, Sherif Rezk, Jack Reid, Elizabeth A Brem, Stefan O Ciurea, Piyanuch Kongtim
Anakinra versus etoposide-based therapy added to high-dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis. European journal of haematology (2023)
Elizabeth A Brem, Susan O'Brien
Is a BTKi or BCL2i preferable for first "novel" therapy in CLL? The case for BTKis. Blood advances 6 (4) (2022)
Elizabeth A Brem, Susan O'Brien
Frontline Management of CLL in 2021. JCO oncology practice (2021)
Sarmen Sarkissian, Yasir Khan, Daniel Farrell, David Constable, Elizabeth A Brem
Hemophagocytic lymphohistiocytosis in the setting of HELLP Syndrome. Clinical case reports 6 (12) (2018)